$LTGO SEC Filings

Filed On	Filing
03 Sep 2026	10-Q
03 Sep 2026	8-K: Results of Operations and Financial Condition
18 Aug 2026	SCHEDULE 13G
17 Aug 2026	SCHEDULE 13D
17 Aug 2026	SCHEDULE 13G
13 Aug 2026	SCHEDULE 13G
12 Aug 2026	Form 4: 5AM Ventures VI, L.p., 10% owner and 5 others Received 7,325,962 shares by conversion
12 Aug 2026	Form 4: Sanofi, 10% owner Received 672,778 shares by conversion
12 Aug 2026	Form 3: Sanofi, 10% owner
11 Aug 2026	Form 4: Westlake BioPartners Fund I, L.p., 10% owner and 5 others Received 12,695,305 shares by conversion
10 Aug 2026	Form 4: Foresite Capital Management V, Llc, 10% owner and 5 others Received 9,041,328 shares by conversion · Bought 140,000 shares ($2.52M)
10 Aug 2026	Form 4: Tananbaum James B., Director Received 9,041,328 shares by conversion · Bought 140,000 shares ($2.52M)
10 Aug 2026	Form 4: Smith Todd N, Director Granted 105,542 Director Stock Option (right to buy)
10 Aug 2026	Form 4: Seidenberg Beth C, Director Received 12,695,305 shares by conversion
10 Aug 2026	S-8
10 Aug 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
07 Aug 2026	424B4
06 Aug 2026	EFFECT
06 Aug 2026	Form 3: Foresite Capital Management V, Llc, 10% owner and 5 others
06 Aug 2026	Form 3: Westlake BioPartners Fund I, L.p., 10% owner and 5 others Holds 429,553 shares of Common Stock

Comments